Literature DB >> 31060373

Association of Arsenic Exposure With Cardiac Geometry and Left Ventricular Function in Young Adults.

Gernot Pichler1,2,3, Maria Grau-Perez1,2,4, Maria Tellez-Plaza2,5,6, Jason Umans7,8, Lyle Best9, Shelley Cole10, Walter Goessler11, Kevin Francesconi11, Jonathan Newman12, Josep Redon2,13, Richard Devereux14, Ana Navas-Acien1.   

Abstract

BACKGROUND: Arsenic exposure has been related to numerous adverse cardiovascular outcomes. The aim of this study was to investigate the cross-sectional and prospective association between arsenic exposure with echocardiographic measures of left ventricular (LV) geometry and functioning.
METHODS: A total of 1337 young adult participants free of diabetes mellitus and cardiovascular disease were recruited from the SHFS (Strong Heart Family Study). The sum of inorganic and methylated arsenic concentrations in urine (ΣAs) at baseline was used as a biomarker of arsenic exposure. LV geometry and functioning were assessed using transthoracic echocardiography at baseline and follow-up.
RESULTS: Mean follow-up was 5.6 years, and median (interquartile range) of ΣAs was 4.2 (2.8-6.9) µg/g creatinine. Increased arsenic exposure was associated with prevalent LV hypertrophy, with an odds ratio (95% CI) per a 2-fold increase in ΣAs of 1.47 (1.05-2.08) in all participants and of 1.58 (1.04-2.41) among prehypertensive or hypertensive individuals. Measures of LV geometry, including LV mass index, left atrial systolic diameter, interventricular septum, and LV posterior wall thickness, were positively and significantly related to arsenic exposure. Among measures of LV functioning, stroke volume, and ejection fraction were associated with arsenic exposure.
CONCLUSIONS: Arsenic exposure was related to an increase in LV wall thickness and LV hypertrophy in young American Indians with a low burden of cardiovascular risk factors. The relationship was stronger in participants with prehypertension or hypertension, suggesting that potential cardiotoxic effects of arsenic might be more pronounced in individuals already undergoing cardiovascular adaptive mechanisms following elevated systemic blood pressure.

Entities:  

Keywords:  arsenic; blood pressure; echocardiography; heart failure; hypertension; hypertrophy, left ventricular

Mesh:

Substances:

Year:  2019        PMID: 31060373      PMCID: PMC6668025          DOI: 10.1161/CIRCIMAGING.119.009018

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  64 in total

Review 1.  Noninvasive surrogate markers of atherosclerosis.

Authors:  Steven B Feinstein; Paolo Voci; Francesco Pizzuto
Journal:  Am J Cardiol       Date:  2002-03-07       Impact factor: 2.778

2.  Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan.

Authors:  Chin-Hsiao Tseng; Choon-Khim Chong; Ching-Ping Tseng; Yu-Mei Hsueh; Hung-Yi Chiou; Ching-Chung Tseng; Chien-Jen Chen
Journal:  Toxicol Lett       Date:  2003-01-31       Impact factor: 4.372

3.  Genetic and environmental contributions to cardiovascular disease risk in American Indians: the strong heart family study.

Authors:  Kari E North; Barbara V Howard; Thomas K Welty; Lyle G Best; Elisa T Lee; J L Yeh; Richard R Fabsitz; Mary J Roman; Jean W MacCluer
Journal:  Am J Epidemiol       Date:  2003-02-15       Impact factor: 4.897

4.  Prognostic implications of ejection fraction from linear echocardiographic dimensions: the Strong Heart Study.

Authors:  Richard B Devereux; Mary J Roman; Vittorio Palmieri; Jennifer E Liu; Elisa T Lee; Lyle G Best; Richard R Fabsitz; Richard J Rodeheffer; Barbara V Howard
Journal:  Am Heart J       Date:  2003-09       Impact factor: 4.749

Review 5.  Surrogate end points in heart failure.

Authors:  Inder S Anand; Viorel G Florea; Lloyd Fisher
Journal:  J Am Coll Cardiol       Date:  2002-05-01       Impact factor: 24.094

6.  Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore.

Authors:  N Larochette; D Decaudin; E Jacotot; C Brenner; I Marzo; S A Susin; N Zamzami; Z Xie; J Reed; G Kroemer
Journal:  Exp Cell Res       Date:  1999-06-15       Impact factor: 3.905

7.  Natural history of asymptomatic left ventricular systolic dysfunction in the community.

Authors:  Thomas J Wang; Jane C Evans; Emelia J Benjamin; Daniel Levy; Elizabeth C LeRoy; Ramachandran S Vasan
Journal:  Circulation       Date:  2003-08-11       Impact factor: 29.690

8.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.

Authors:  S Yusuf; B Pitt; C E Davis; W B Hood; J N Cohn
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

9.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.

Authors:  Margaret M Redfield; Steven J Jacobsen; John C Burnett; Douglas W Mahoney; Kent R Bailey; Richard J Rodeheffer
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

10.  Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study).

Authors:  M S Lauer; J C Evans; D Levy
Journal:  Am J Cardiol       Date:  1992-11-01       Impact factor: 2.778

View more
  11 in total

Review 1.  A Clinical Perspective on Arsenic Exposure and Development of Atherosclerotic Cardiovascular Disease.

Authors:  Gurleen Kaur; Karan P Desai; Isabella Y Chang; Jonathan D Newman; Roy O Mathew; Sripal Bangalore; Ferdinand J Venditti; Mandeep S Sidhu
Journal:  Cardiovasc Drugs Ther       Date:  2022-01-14       Impact factor: 3.727

2.  Cardiovascular Health in American Indians and Alaska Natives: A Scientific Statement From the American Heart Association.

Authors:  Khadijah Breathett; Mario Sims; Marie Gross; Elizabeth A Jackson; Emily J Jones; Ana Navas-Acien; Herman Taylor; Kevin L Thomas; Barbara V Howard
Journal:  Circulation       Date:  2020-05-28       Impact factor: 29.690

3.  Arsenic, blood pressure, and hypertension in the Strong Heart Family Study.

Authors:  John A Kaufman; Claire Mattison; Amanda M Fretts; Jason G Umans; Shelley A Cole; V Saroja Voruganti; Walter Goessler; Lyle G Best; Ying Zhang; Maria Tellez-Plaza; Ana Navas-Acien; Matthew O Gribble
Journal:  Environ Res       Date:  2021-02-11       Impact factor: 6.498

4.  Inorganic arsenic induces sex-dependent pathological hypertrophy in the heart.

Authors:  Raihan Kabir; Prithvi Sinha; Sumita Mishra; Obialunanma V Ebenebe; Nicole Taube; Chistian U Oeing; Gizem Keceli; Rui Chen; Nazareno Paolocci; Ana Rule; Mark J Kohr
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-01-22       Impact factor: 4.733

5.  Assessment of Diastolic Function and Thiol-Disulphide Homeostasis in Arsenic-Exposed Workers.

Authors:  Ugur Nadir Karakulak; Ceylan Bal; Meside Gunduzoz; Murat Buyuksekerci; Elifcan Aladag; Mehmet Levent Sahiner; Ergun Baris Kaya; Necla Ozer; Omer Hinc Yilmaz; Ozcan Erel
Journal:  Acta Cardiol Sin       Date:  2021-01       Impact factor: 2.672

6.  Arsenic Exposure and Melanoma Among US Adults Aged 20 or Older, 2003-2016.

Authors:  Ahmed Bedaiwi; Ashley Wysong; Eleanor G Rogan; Dillon Clarey; Christine M Arcari
Journal:  Public Health Rep       Date:  2021-05-10       Impact factor: 3.117

7.  Mixed organic and inorganic tapwater exposures and potential effects in greater Chicago area, USA.

Authors:  Paul M Bradley; Maria Argos; Dana W Kolpin; Shannon M Meppelink; Kristin M Romanok; Kelly L Smalling; Michael J Focazio; Joshua M Allen; Julie E Dietze; Michael J Devito; Ariel R Donovan; Nicola Evans; Carrie E Givens; James L Gray; Christopher P Higgins; Michelle L Hladik; Luke R Iwanowicz; Celeste A Journey; Rachael F Lane; Zachary R Laughrey; Keith A Loftin; R Blaine McCleskey; Carrie A McDonough; Elizabeth Medlock-Kakaley; Michael T Meyer; Andrea R Putz; Susan D Richardson; Alan E Stark; Christopher P Weis; Vickie S Wilson; Abderrahman Zehraoui
Journal:  Sci Total Environ       Date:  2020-02-11       Impact factor: 10.753

8.  Key Characteristics of Cardiovascular Toxicants.

Authors:  Lars Lind; Jesus A Araujo; Aaron Barchowsky; Scott Belcher; Brian R Berridge; Nipavan Chiamvimonvat; Weihsueh A Chiu; Vincent J Cogliano; Sarah Elmore; Aimen K Farraj; Aldrin V Gomes; Cliona M McHale; Kathleen B Meyer-Tamaki; Nikki Gillum Posnack; Hugo M Vargas; Xi Yang; Lauren Zeise; Changcheng Zhou; Martyn T Smith
Journal:  Environ Health Perspect       Date:  2021-09-24       Impact factor: 9.031

Review 9.  Recent Progress in Environmental Toxins-Induced Cardiotoxicity and Protective Potential of Natural Products.

Authors:  Yuanying Yang; Shanshan Wei; Bikui Zhang; Wenqun Li
Journal:  Front Pharmacol       Date:  2021-07-08       Impact factor: 5.810

10.  Urinary arsenic and heart disease mortality in NHANES 2003-2014.

Authors:  Anne E Nigra; Katherine A Moon; Miranda R Jones; Tiffany R Sanchez; Ana Navas-Acien
Journal:  Environ Res       Date:  2021-06-06       Impact factor: 8.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.